Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NQO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
POLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0368 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RSPH10B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PACS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HUWE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALCRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNLIPRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UMPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSME3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PELO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on